After 30 years with Hewlett-Packard and spin-off Agilent Technologies, Chris van Ingen retired this week. He has spent the last seven years as president of the Bio-Analytical Measurement business, formerly the Life Sciences and Chemical Analysis unit.
 
Last week, in an interview with BioCommerce Week van Ingen reflected on his years with Agilent and how the company and industry have changed during his tenure. The following is an edited version of that interview.
 

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.